Combined impact of rituximab and target care on efficacy, quality of life, adverse reactions and recurrence rate in children with nephrotic syndrome: a randomized controlled trial

Authors

Institutions

Publication Details

Journal
BMC Pediatrics
Published
2025-09-24
DOI
https://doi.org/10.1186/s12887-025-06070-0
Citations
1
Primary Topic
Renal Diseases and Glomerulopathies
Type
article
Field-Weighted Citation Impact
1.43
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Combined impact of rituximab and target care on efficacy, quality of life, adverse reactions and recurrence rate in children with nephrotic syndrome: a randomized controlled trial

Lanfen He, Lian Yang, Heng Mei, Ting Xu et al.
1 citations
BMC Pediatrics
Renal Diseases and Glomerulopathies
1.43
article

Combined impact of rituximab and target care on efficacy, quality of life, adverse reactions and recurrence rate in children with nephrotic syndrome: a randomized controlled trial

Lanfen He, Lian Yang, Heng Mei, Ting Xu, Xiaofeng Wang, Xiaolu Li, Yan Gu, Zeng Liu
article en
1 citations

Abstract

No abstract available for this paper.
BMC PediatricsVol. 25(1)
Wuhan Children's Hospital (CN)
Openalex Percentile: Top 16%
Renal Diseases and Glomerulopathies
1.43
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.